Wolverine Clinical Trials

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Obesity2 trials
• Type 2 diabetes2 trials
• Atopic dermatitis (eczema)1 trial
• Hidradenitis suppurativa1 trial
• Lupus (SLE)1 trial
• Osteoarthritis1 trial
• Vitiligo1 trial

Phase

• Phase 34 trials
• Phase 23 trials

Status

• Active, not recruiting2 trials
• Completed2 trials
• Recruiting2 trials
• Not yet recruiting1 trial

Lead sponsor

• Eli Lilly and Company3 trials
• Pfizer3 trials
• Janssen Research & Development, LLC1 trial

Running trials

• Recruiting

  A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema

  NCT07783425· Phase 3· Pfizer· Source

• Recruiting

  Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

  NCT07353931· Phase 3· Eli Lilly and Company· Source

  Contact: Behnam Khaleghi (principal investigator)

• Active, not recruiting

  A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.

  NCT07228390· Phase 2· Pfizer· Source

• Recruiting

  A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

  NCT06897475· Phase 2· Eli Lilly and Company· Source

  Contact: Behnam Khaleghi (principal investigator)

• Active, not recruiting

  A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2

  NCT06072183· Phase 3· Pfizer· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity2 recruiting
• Atopic dermatitis (eczema)1 recruiting
• Osteoarthritis1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin

  NCT06192108· Phase 3· Eli Lilly and Company· Source

• Completed

  A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus

  NCT04882878· Phase 2· Janssen Research & Development, LLC· Source